John D. Zehren
Direktor/Vorstandsmitglied bei Singlepass, Inc.
Aktive Positionen von John D. Zehren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Singlepass, Inc.
 Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Direktor/Vorstandsmitglied | 18.03.2022 | - |
| Independent Dir/Board Member | 18.03.2022 | - |
Karriereverlauf von John D. Zehren
Ehemalige bekannte Positionen von John D. Zehren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENDOLOGIX, INC. | Corporate Officer/Principal | 07.01.2019 | 14.04.2020 |
Ausbildung von John D. Zehren
| University of St. Thomas | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Singlepass, Inc.
Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |
- Börse
- Insiders
- John D. Zehren
- Erfahrung
